A. Okunade

Epidemiology · Proceedings of the National Academy of Sciences of the United States of America · 2009–2019

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom A. Okunade trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Klein (in Epidemiology)

Who trusts A. Okunade

  1. Gerald I. Shulman (in Epidemiology)
  2. V. Samuel (in Physiology)

Papers from A. Okunade's perspective

Ordered by how strongly the researchers A. Okunade trusts endorse each paper. Same corpus, a different order for every researcher.

  1. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis. (New England Journal of Medicine)
  2. Obesity and Free Fatty Acids (FFA) (Endocrinology and metabolism clinics of North America (Print))
  3. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. (Journal of Clinical Investigation)
  4. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. (New England Journal of Medicine)
  5. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. (Journal of Clinical Investigation)
  6. Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans (Diabetes)
  7. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action (Nature Medicine)
  8. Abdominal obesity and metabolic syndrome (Nature)
  9. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. (Gastroenterology)
  10. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. (Gastroenterology)

Their papers